Chemical Compound

Apratastat

CAS Registry Number 287405-51-0
Apratastat chemical structure
Primary Record

Apratastat

In stock
7,847 g
Purity
98.8 %
CAS
287405-51-0

Compound Identifiers & Properties

CAS
287405-51-0
PubChem CID
11452716
SMILES
CC1([C@@H](N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C
Canonical SMILES
CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO

Names & Synonyms

  • Apratastat
  • apratastatum
  • TMI-005
  • 287405-51-0
  • Apratastat [USAN]
  • TMI-05
  • TMI 005
  • Apratastat [USAN:INN]
  • TMI-1
  • APRATASTAT [INN]
  • Apratastat (USAN/INN)
  • RefChem:558431
  • C6BZ5263BJ
  • UNII-C6BZ5263BJ
  • D08NFK
  • D0HG5M
  • CHEMBL206815
  • MLS006010301
  • DTXSID10870312
  • GTPL6482
  • orb1707645
  • SCHEMBL2834310
  • TMI005
  • Apratastat, >=98% (HPLC)
  • C17H22N2O6S2
  • CHEBI:177520
  • BCPP000041
  • DTXCID001511187
  • MLA40551
  • BDBM50181008
  • EX-A14846
  • MFCD13152357
  • ZINC28571311
  • AKOS040741161
  • DB13020
  • CID11452716
  • compound 5h [PMID: 16426848]
  • 4CA-0170
  • CID:11452716
  • DA-50651
  • MS-27179
  • SMR004701369
  • SID:160644599
  • HY-119307
  • CS-0066985
  • Dual TACE/MMP-13 inhibitors, Wyeth-Ayerst
  • NS00071827
  • D08859
  • E98872
  • A937207
  • C484302
  • Dual TACE/MMP-13 inhibitors (inflammation), Wyeth
  • BRD-K06883221-001-01-9
  • Q27074484
  • 4-((4-(2-butynyloxy)phenyl)sulfonyl)-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide
  • Dual TACE/MMP-13 inhibitors (rheumatoid arthritis), Wyeth
  • (3S)-N-Hydroxy-4-((4-((4-hydroxybut-2-ynyl)oxy)phenyl)sulfonyl)-2,2-dimethylthiomorpholine-3-carboxamide
  • (3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide
  • (3S)-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethyl-thiomorpholine-3-carbohydroxamic acid
  • (3S)-N-hydroxy-4-(4-((4-hydroxybut-2-yn-1-yl)oxy)benzenesulfonyl)-2,2-dimethylthiomorpholine-3-carboxamide
  • (3S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynoxy)phenyl)sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide
  • (3S)-N-Hydroxy-4-[[4-[(4-hydroxybut-2-ynyl)oxy]phenyl]sulfonyl]-2,2-dimethylthiomorpholine-3-carboxamide
  • (3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulonyl-2,2-dimethylthiomorpholine-3-carboxamide
  • (3S)-N-Hydroxy-4-{4-[(4-hydroxybut-2-yn-1-yl)oxy]benzene-1-sulfonyl}-2,2-dimethylthiomorpholine-3-carboxamide
  • (S)-4-[4-(4-Hydroxy-but-2-ynyloxy)-benzenesulfonyl]-2,2-dimethyl-thiomorpholine-3-carboxylic acid hydroxyamide
  • (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynyloxy)phenylsulfonyl)-2,2-dimethylthiomorpholine-3-carboxamide
  • 3-THIOMORPHOLINECARBOXAMIDE, N-HYDROXY-4-((4-((4-HYDROXY-2-BUTYNYL)OXY)PHENYL)SULFONYL)-2,2-DIMETHYL, (3S)-
  • 3-Thiomorpholinecarboxamide,N-hydroxy-4-[[4-[(4-hydroxy-2-butyn-1-yl)oxy]phenyl]sulfonyl]-2,2-dimethyl-,(3S)-
  • N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethyl-thiomorpholine-3-carboxamide